Literature DB >> 10869555

Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase.

M Koyama1, M Ito, J Feng, T Seko, K Shiraki, K Takase, D J Hartshorne, T Nakano.   

Abstract

Phosphorylation of CPI-17 by Rho-associated kinase (Rho-kinase) and its effect on myosin phosphatase (MP) activity were investigated. CPI-17 was phosphorylated by Rho-kinase to 0.92 mol of P/mol of CPI-17 in vitro. The inhibitory phosphorylation site was Thr(38) (as reported previously) and was identified using a point mutant of CPI-17 and a phosphorylation state-specific antibody. Phosphorylation by Rho-kinase dramatically increased the inhibitory effect of CPI-17 on MP activity. Thus, CPI-17 as a substrate of Rho-kinase could be involved in the Ca(2+) sensitization of smooth muscle contraction as a downstream effector of Rho-kinase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869555     DOI: 10.1016/s0014-5793(00)01654-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  68 in total

1.  Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle.

Authors:  T P Woodsome; M Eto; A Everett; D L Brautigan; T Kitazawa
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

2.  Microtubule disruption modulates the Rho-kinase pathway in vascular smooth muscle.

Authors:  D Zhang; Z Wang; N Jin; L Li; R A Rhoades; K W Yancey; D R Swartz
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

Review 3.  The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.

Authors:  Rachel S Knipe; Andrew M Tager; James K Liao
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 4.  Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle myosin light chain.

Authors:  Katusya Hirano; Dmitry N Derkach; Mayumi Hirano; Junji Nishimura; Hideo Kanaide
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

5.  A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.

Authors:  Christina Pagiatakis; Joseph W Gordon; Saviz Ehyai; John C McDermott
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

Review 6.  A role for the Ca(2+)-dependent tyrosine kinase Pyk2 in tonic depolarization-induced vascular smooth muscle contraction.

Authors:  Ryan D Mills; Mitsuo Mita; Michael P Walsh
Journal:  J Muscle Res Cell Motil       Date:  2015-07-07       Impact factor: 2.698

7.  GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKA.

Authors:  Qing-Rong Liu; Ping-Wu Zhang; Zhicheng Lin; Qi-Fu Li; Amina S Woods; Juan Troncoso; George R Uhl
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

8.  PKC and Rho in vascular smooth muscle: activation by BOXes and SAH CSF.

Authors:  Gail J Pyne-Geithman; Sunil G Nair; Danielle N Caudell; Joseph F Clark
Journal:  Front Biosci       Date:  2008-01-01

9.  Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway.

Authors:  Karnam S Murthy; Huiping Zhou; John R Grider; David L Brautigan; Masumi Eto; Gabriel M Makhlouf
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

Review 10.  The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.

Authors:  Karl Swärd; Mitsuo Mita; David P Wilson; Jing Ti Deng; Marija Susnjar; Michael P Walsh
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.